Martilias Farrell, Maya Lichtenstein, Matthew K Harner, James J Crowley, Dawn M Filmyer, Gabriel Lázaro-Muñoz, Tyler E Dietterich, Lisa M Bruno, Rita A Shaughnessy, Tamara F Biondi, Stephan Burkholder, Jane Donmoyer, Jonathan S Berg, Jin Szatkiewicz, Patrick F Sullivan, Richard C Josiassen
Journal: Translational psychiatry 2021;10(1):42
PMID: 32066678
The 15q11.2 BP1-BP2 (Burnside-Butler) deletion is a rare copy number variant impacting four genes (NIPA1, NIPA2, CYFIP1, and TUBGCP5), and carries increased risks for developmental delay, intellectual disability, and neuropsychiatric disorders (attention-deficit/hyperactivity disorder, autism, and psychosis). In this case report (supported by extensive developmental information and medication history), we present the complex clinical portrait of a 44-year-old woman with 15q11.2 BP1-BP2 deletion syndrome and chronic, treatment-resistant psychotic symptoms who has resided nearly her entire adult life in a long-term state psychiatric institution. Diagnostic and treatment implications are discussed.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.